Screening for single nucleotide variants, small indels and exon deletions with a next‐generation sequencing based gene panel approach for Usher syndrome. Issue 5 (15th June 2014)

• Record Type: Journal Article
• Authors: Krawitz, Peter M.; Schiska, Daniela; Krüger, Ulrike; Appelt, Sandra; Heinrich, Verena; Parkhomchuk, Dmitri; Timmermann, Bernd; Millan, Jose M.; Robinson, Peter N.; Mundlos, Stefan; Hecht, Jochen; Gross, Manfred
• Is Part Of: Molecular genetics & genomic medicine. Volume 2:Issue 5(2014:Sep.)
• Page Start: 393
• Page End: 401
• Publication Date: 2014-06-15
• Subjects: Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.92
• Languages: English
• ISSNs: 2324-9269

Abstract

<abstract abstract-type="main" id="mgg392-abs-0001"> <title>Abstract</title> <p>Usher syndrome is an autosomal recessive disorder characterized both by deafness and blindness. For the three clinical subtypes of Usher syndrome causal mutations in altogether 12 genes and a modifier gene have been identified. Due to the genetic heterogeneity of Usher syndrome, the molecular analysis is predestined for a comprehensive and parallelized analysis of all known genes by next‐generation sequencing (NGS) approaches. We describe here the targeted enrichment and deep sequencing for exons of Usher genes and compare the costs and workload of this approach compared to Sanger sequencing. We also present a bioinformatics analysis pipeline that allows us to detect single‐nucleotide variants, short insertions and deletions, as well as copy number variations of one or more exons on the same sequence data. Additionally, we present a flexible in silico gene panel for the analysis of sequence variants, in which newly identified genes can easily be included. We applied this approach to a cohort of 44 Usher patients and detected biallelic pathogenic mutations in 35 individuals and monoallelic mutations in eight individuals of our cohort. Thirty‐nine of the sequence variants, including two heterozygous deletions comprising several exons of USH2A, have not been reported so far. Our NGS‐based approach allowed us to assess single‐nucleotide variants, small indels, and whole exon deletions in a single test. The described diagnostic approach is fast and cost‐effective with a high molecular diagnostic yield.</p> </abstract>